chr11-17609906-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001292063.2(OTOG):c.4606C>T(p.Leu1536Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,521,602 control chromosomes in the GnomAD database, including 96 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.4606C>T | p.Leu1536Phe | missense_variant | 36/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.4642C>T | p.Leu1548Phe | missense_variant | 35/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.4606C>T | p.Leu1536Phe | missense_variant | 36/56 | 5 | NM_001292063.2 | ENSP00000382329.2 | ||
OTOG | ENST00000399391.7 | c.4642C>T | p.Leu1548Phe | missense_variant | 35/55 | 5 | ENSP00000382323.2 | |||
OTOG | ENST00000342528.2 | n.1944C>T | non_coding_transcript_exon_variant | 12/22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00800 AC: 1215AN: 151962Hom.: 9 Cov.: 32
GnomAD3 exomes AF: 0.00823 AC: 1023AN: 124278Hom.: 5 AF XY: 0.00822 AC XY: 535AN XY: 65124
GnomAD4 exome AF: 0.0110 AC: 15009AN: 1369522Hom.: 87 Cov.: 31 AF XY: 0.0110 AC XY: 7365AN XY: 671574
GnomAD4 genome AF: 0.00798 AC: 1213AN: 152080Hom.: 9 Cov.: 32 AF XY: 0.00772 AC XY: 574AN XY: 74336
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 20, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | OTOG: BP4, BS1, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 23, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Leu1548Phe in exon 35 of OTOG: This variant is not expected to have clinical sig nificance because it has been identified in 4.2% (5/120) of Colombian chromosome s from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.g ov/projects/SNP; dbSNP rs117380920). - |
Meniere disease Benign:1
Likely benign, criteria provided, single submitter | case-control | Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) | Jan 01, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at